Manuel Vázquez Carre

Investigador

[Manuel Vázquez Carre @Manelix7]

I am pleased to share the publication of our latest review article “The emerging role of PPARs in primary biliary cholangitis” now available online (June 2026) in Trends in Molecular Medicine.
My sincere thanks to all collaborators.
https://t.co/vZr47IhFRZ

[Manuel Vázquez Carre @Manelix7]

https://t.co/JbI0VtYL7X

[Dr Alexey Kulikov @KulikovUNIATF]

New research highlights a striking #metabolic clash:

Palmitic 🌴acid (common in palm oil, meat, and butter) promotes insulin resistance and type 2 #diabetes by driving toxic ceramides, inflammation, and organelle stress - while oleic acid (the main fat in olive 🫒 oil) counteracts these effects, shunting harmful fats into safer storage.

https://t.co/8pnjBwNSoV

[Daniel J Drucker @DanielJDrucker]

How do GLP-1 meds improve liver health through #weightloss independent mechanisms? Here @ChusaGzlzRellan & colleagues identify Liver Sinusoidal Endothelial Cells as direct targets of semaglutide, linking LSECs to reduction of #inflammation #Fibrosis #MASH https://t.co/c5FXIs2hTO

[Manuel Vázquez Carre @Manelix7]

I am pleased to share the publication of our latest review article
“Palmitic and oleic acids in type 2 diabetes mellitus” now available online (March 29, 2026) in Trends in Endocrinology and Metabolism.
https://t.co/d9MsrScDkv

[Manuel Vázquez Carre @Manelix7]

I am pleased to share the publication of our latest review article
“Palmitic and oleic acids in type 2 diabetes mellitus” now available online (March 29, 2026) in Trends in Endocrinology and Metabolism.
https://t.co/d9MsrScDkv

[FatLiv_Lab @FatlivL]

Congratulations to @Manelix7 team for this great job 👏 !! We are very grateful to have participated in this project 😊. Now that World Diabetes Day is approaching, it is important to highlight the relevance of these studies in this field 💊

[CIBER ISCIII @CIBER_ISCIII]

Un estudio colaborativo #CIBERDEM identifica un nuevo mecanismo molecular que contribuye a explicar los efectos beneficiosos de la #metformina, el fármaco más prescrito para la #diabetes tipo 2 💊

🆕https://t.co/GXUYr5CVdB

[Oded Rechavi @OdedRechavi]

How I feel when I submit a grant I care about

[Oded Rechavi @OdedRechavi]

Re-submitting the paper to other journals

[CardioTeca @cardioteca]

📘 GDF15 como biomarcador para identificar etiología isquémica en insuficiencia cardíaca con déficit de hierro

Cristina Enjuanes Grau

📎 Lee el comentario completo aquí: https://t.co/nTfMb3qWzA

🔬 Niveles elevados de GDF15 se asociaron con peor función del ventrículo derecho y menor capacidad funcional
📉 Su relación inversa con la hemoglobina sugiere un papel en la homeostasis del hierro
🧪 GDF15 mejoró la precisión para identificar la etiología isquémica en pacientes con IC y déficit de hierro
🩺 El estudio refuerza el valor de los biomarcadores para comprender mejor la patogenia y estratificación de la IC

[Oded Rechavi @OdedRechavi]

"It's not the end of the world, let's just send it to another journal"

[Oded Rechavi @OdedRechavi]

Opening a "Decision on your Manuscript" email

[Oded Rechavi @OdedRechavi]

Co-authors when you ask them to go over a draft in August

[Oded Rechavi @OdedRechavi]

The manuscript resubmitted to different journals

[Diario Médico @diariomedico]

📢Un factor inesperado en #InsuficienciaCardíaca🫀: la proteína GADD45A. Investigadores de la Facultad de Farmacia de la @UniBarcelona hallan evidencia de que potenciarla podría frenar la hipertrofia del corazón.

https://t.co/CuzEWm9WAN

[IBUB-UB @IBUB_UB]

TOMORRW! #IBUBSeminar "Substrate metabolism in health and disease" by Arzu BEŞİKCİ @AnkaraUni_en

🗓️Wed 4
⏰12:00h
🚩A3, @Farmacia_UB

[Manuel Vázquez Carre @Manelix7]

@Neuroepigeneti1 Congrats!!!!!